Multiple Myeloma section

Multiple Myeloma News & Features

Prior diagnosis of MGUS improves survival in patients with multiple myeloma

Prior diagnosis of MGUS improves survival in patients with multiple myeloma

Patients with multiple myeloma seem to have improves survival if they are found to have monoclonal gammopathy of undetermined significance (MGUS) first.

Farydak (panobinostat) now FDA-approved for multiple myeloma

Farydak (panobinostat) now FDA-approved for multiple myeloma

Drug is now sanctioned for people who have received at least two prior standard therapies.

Novel drug approved for multiple myeloma

Novel drug approved for multiple myeloma

The FDA has approved Farydak (panobinostat) in combination with bortezomib and dexamethasone for the treatment of multiple myeloma.

Lenalidomide receives FDA approval for expanded use in multiple myeloma

Lenalidomide receives FDA approval for expanded use in multiple myeloma

Celgene received FDA approval to expand the indications for lenaliodomide (Revlimid) to include treatment of newly diagnosed multiple myeloma.

New recommendations released for MRI use in multiple myeloma

New recommendations released for MRI use in multiple myeloma

Magnetic resonance imaging (MRI) is gold standard for imaging axial skeleton, assessing painful lesions, and identification of benign fractures.

April Contest

Click here to get started

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs